New England Biolabs and seqWell join forces to commercialize TnX transposase, aiming to enhance next-generation sequencing library preparation workflows through combined manufacturing and technical expertise.
Strategic partnership with seqWell to commercialize TnX transposase leverages NEB's enzyme development and manufacturing expertise.
Commercial launch of TnX-based NGS library preparation solutions with NEB expands seqWell's product portfolio and market reach.
New England Biolabs and seqWell have entered a strategic partnership to commercialize TnX transposase technology. The collaboration combines NEB's expertise in enzyme manufacturing with seqWell's NGS library preparation solutions to expand market reach.
The partnership aims to commercialize TnX transposase-based NGS library preparation solutions by combining seqWell's technology with NEB's enzyme development and manufacturing capabilities.